Iovance Biotherapeutics, Inc. (IOVA) DCF Valuation

Iovance Biotherapeutics, Inc. (IOVA) DCF Valuation
  • ✓ Entièrement Modifiable: Adapté À Vos Besoins Dans Excel Ou Sheets
  • ✓ Conception Professionnelle: Modèles Fiables Et Conformes Aux Normes Du Secteur
  • ✓ Pré-Construits Pour Une Utilisation Rapide Et Efficace
  • ✓ Aucune Expertise N'Est Requise; Facile À Suivre

Iovance Biotherapeutics, Inc. (IOVA) Bundle

DCF model
Get Full Bundle:
$25 $15
$12 $7
$12 $7
$12 $7
$12 $7
$12 $7
$12 $7
$12 $7
$12 $7

TOTAL:

Looking to assess the intrinsic value of Iovance Biotherapeutics, Inc.? Our (IOVA) DCF Calculator integrates real-world data with comprehensive customization features, allowing you to refine your forecasts and make more informed investment choices.


Discounted Cash Flow (DCF) - (USD MM)

Year AY1
2019		 AY2
2020		 AY3
2021		 AY4
2022		 AY5
2023		 FY1
2024		 FY2
2025		 FY3
2026		 FY4
2027		 FY5
2028
Revenue .0 .0 .0 .0 1.2 1.2 1.2 1.2 1.2 1.2
Revenue Growth, % 0 0 0 0 0 0 0 0 0 0
EBITDA -189.4 -250.9 -328.3 -374.8 -427.4 .7 .7 .7 .7 .7
EBITDA, % 100 100 100 100 -35948.86 60 60 60 60 60
Depreciation 8.1 8.7 14.0 21.1 33.1 1.2 1.2 1.2 1.2 1.2
Depreciation, % 100 100 100 100 2786.12 100 100 100 100 100
EBIT -197.6 -259.6 -342.3 -395.9 -460.6 .7 .7 .7 .7 .7
EBIT, % 100 100 100 100 -38734.99 60 60 60 60 60
Total Cash 307.1 629.4 596.0 471.8 279.9 1.2 1.2 1.2 1.2 1.2
Total Cash, percent .0 .0 .0 .0 .0 .0 .0 .0 .0 .0
Account Receivables .0 .0 .0 .0 .2
Account Receivables, % 100 100 100 100 12.7
Inventories .0 .0 .0 .0 10.4 1.2 1.2 1.2 1.2 1.2
Inventories, % 100 100 100 100 872.33 100 100 100 100 100
Accounts Payable 15.6 13.5 27.4 26.6 33.1 1.2 1.2 1.2 1.2 1.2
Accounts Payable, % 100 100 100 100 2785.79 100 100 100 100 100
Capital Expenditure -6.9 -46.8 -37.6 -20.4 -22.3 -.2 -.2 -.2 -.2 -.2
Capital Expenditure, % 100 100 100 100 -1874.68 -20 -20 -20 -20 -20
Tax Rate, % 0.7774 0.7774 0.7774 0.7774 0.7774 0.7774 0.7774 0.7774 0.7774 0.7774
EBITAT -187.1 -257.2 -327.8 -389.9 -457.0 .7 .7 .7 .7 .7
Depreciation
Changes in Account Receivables
Changes in Inventories
Changes in Accounts Payable
Capital Expenditure
UFCF -170.3 -297.4 -337.6 -390.0 -450.1 -21.9 1.6 1.6 1.6 1.6
WACC, % 7.13 7.13 7.13 7.13 7.13 7.13 7.13 7.13 7.13 7.13
PV UFCF
SUM PV UFCF -15.3
Long Term Growth Rate, % 2.00
Free cash flow (T + 1) 2
Terminal Value 33
Present Terminal Value 23
Enterprise Value 8
Net Debt -39
Equity Value 47
Diluted Shares Outstanding, MM 235
Equity Value Per Share 0.20

What You Will Receive

  • Pre-Filled Financial Model: Iovance Biotherapeutics' actual data provides an accurate DCF valuation.
  • Comprehensive Forecast Control: Modify revenue growth, profit margins, WACC, and other essential factors.
  • Real-Time Calculations: Automatic updates allow you to view results instantly as you make adjustments.
  • Professional-Grade Template: A polished Excel file crafted for high-quality valuation.
  • Flexible and Reusable: Designed for adaptability, enabling repeated application for in-depth forecasts.

Key Features

  • 🔍 Real-Life IOVA Financials: Pre-filled historical and projected data for Iovance Biotherapeutics, Inc. (IOVA).
  • ✏️ Fully Customizable Inputs: Adjust all critical parameters (yellow cells) like WACC, growth %, and tax rates.
  • 📊 Professional DCF Valuation: Built-in formulas calculate Iovance’s intrinsic value using the Discounted Cash Flow method.
  • ⚡ Instant Results: Visualize Iovance’s valuation instantly after making changes.
  • Scenario Analysis: Test and compare outcomes for various financial assumptions side-by-side.

How It Works

  • Download: Obtain the pre-built Excel file containing Iovance Biotherapeutics, Inc. (IOVA) financial data.
  • Customize: Modify projections, including revenue growth, EBITDA %, and WACC as needed.
  • Update Automatically: The intrinsic value and NPV calculations refresh in real-time.
  • Test Scenarios: Generate various projections and analyze results immediately.
  • Make Decisions: Leverage the valuation outcomes to inform your investment approach.

Why Choose This Calculator for Iovance Biotherapeutics, Inc. (IOVA)?

  • User-Friendly Interface: Perfectly crafted for both novice and seasoned users.
  • Customizable Inputs: Adjust parameters easily to tailor your financial analysis.
  • Real-Time Feedback: Instantly observe changes in Iovance's valuation as you modify inputs.
  • Pre-Configured Data: Comes with Iovance’s actual financial statistics for swift evaluations.
  • Relied Upon by Experts: Favored by investors and analysts for making well-informed choices.

Who Should Use This Product?

  • Investors: Evaluate Iovance Biotherapeutics’ (IOVA) market potential before making investment decisions.
  • CFOs and Financial Analysts: Optimize valuation methodologies and assess financial forecasts.
  • Startup Founders: Understand the valuation processes of innovative biotech firms like Iovance.
  • Consultants: Create comprehensive valuation reports for biotech clients.
  • Students and Educators: Utilize current data to learn and teach valuation strategies in the biotech sector.

What the Template Contains

  • Operating and Balance Sheet Data: Pre-filled Iovance Biotherapeutics historical data and forecasts, including revenue, EBITDA, EBIT, and capital expenditures.
  • WACC Calculation: A dedicated sheet for Weighted Average Cost of Capital (WACC), including parameters like Beta, risk-free rate, and share price.
  • DCF Valuation (Unlevered and Levered): Editable Discounted Cash Flow models showing intrinsic value with detailed calculations.
  • Financial Statements: Pre-loaded financial statements (annual and quarterly) to support analysis.
  • Key Ratios: Includes profitability, leverage, and efficiency ratios for Iovance Biotherapeutics, Inc. (IOVA).
  • Dashboard and Charts: Visual summary of valuation outputs and assumptions to analyze results easily.

No products were found matching.